AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Medrok G 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Abdach Healthcare Pvt. Ltd.

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Medrok G 2mg/500mg Tablet SR

Diabetic patients using Glyconia-D 2mg/500mg extended-release tablets should be aware that this medication combines two anti-diabetic agents for type 2 diabetes management in adults. Its primary function is blood glucose regulation. Consistent daily intake, always with food, at the same time, maximizes effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Discontinuation without medical supervision is strongly discouraged, as it may lead to uncontrolled blood sugar, potentially resulting in complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is only one component of a comprehensive diabetes management plan, which should include a doctor-recommended diet, regular physical activity, and weight management. Commonly observed adverse effects include hypoglycemia (low blood sugar). Learn to identify hypoglycemic symptoms (sweating, lightheadedness, headache, tremors) and how to treat them promptly with a quick-acting glucose source (e.g., sugary foods or juice). Alcohol consumption elevates hypoglycemia risk and should be minimized. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain is also a possibility. Glyconia-D 2mg/500mg extended-release tablets are contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to check blood cell counts and liver function) are essential.

Uses of Medrok G 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Medrok G 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Medrok G 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Medrok G 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Medrok G 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Medrok G 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Medrok G 2mg/500mg Tablet SR works:

Medrok G SR tablets (2mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar levels. Metformin, a biguanide, acts through a triple mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Medrok G 2mg/500mg Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Medrok G 2mg/500mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Medrok G 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Medrok G 2mg/500mg SR tablets cautiously, potentially requiring dosage modifications. Severe kidney disease contraindicates the use of Medrok G 2mg/500mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Medrok G 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, initiation with a low dose is typical; however, it's contraindicated in those with severe liver disease.

What if you forget to take Medrok G 2mg/500mg Tablet SR :

Should you forget to take a Medrok G 2mg/500mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Medrok G 2mg/500mg Tablet SR

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Medrok G 2mg/500mg Tablet SR

Store this medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Medrok G 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia warrant immediate discontinuation of Medrok G 2mg/500mg Tablet SR and prompt medical attention.
The extended-release tablet Medrok G 2mg/500mg combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This dual-action medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and improves cellular responsiveness to insulin. This formulation is unsuitable for type 1 diabetes mellitus.
Medrok G 2mg/500mg sustained-release tablets may cause common adverse events including hypoglycemia, altered taste perception, nausea, abdominal pain, diarrhea, and cephalalgia. Rare, but potentially serious, side effects such as lactic acidosis may occur. Prolonged therapy may result in vitamin B12 deficiency.
Medrok G 2mg/500mg SR tablets can induce Vitamin B12 deficiency with prolonged use due to interference with its gastric absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, weakness, urinary dysfunction, cognitive impairment, and ataxia. Prophylactic supplemental Vitamin B12, at least annually, is recommended by some researchers to mitigate these risks.
Medrok G 2mg/500mg SR tablets can induce hypoglycemia. Low blood sugar symptoms may include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Medrok G 2mg/500mg SR tablets with alcohol is inadvisable due to the risk of dangerously low blood sugar (hypoglycemia). Concurrent use also raises the likelihood of lactic acidosis.
Medrok G 2mg/500mg Tablet...
57
MRP 70
18% off